Agilent GenetiSure Dx Postnatal Assay

Agilent Technologies has launched the GenetiSure Dx Postnatal Assay. The assay uses the company's comparative genomic hybridization technology, which provides data on copy number variations and absence of heterozygosity. The test will help clinical labs implement cytogenetic testing, Agilent said.


Lexogen Quantitative RNA-Seq Service

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.

CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.

The New York Times reports on a project to develop a tree DNA database to uncover illegal logging.

In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.